JP2024001040A5 - - Google Patents

Info

Publication number
JP2024001040A5
JP2024001040A5 JP2023151499A JP2023151499A JP2024001040A5 JP 2024001040 A5 JP2024001040 A5 JP 2024001040A5 JP 2023151499 A JP2023151499 A JP 2023151499A JP 2023151499 A JP2023151499 A JP 2023151499A JP 2024001040 A5 JP2024001040 A5 JP 2024001040A5
Authority
JP
Japan
Prior art keywords
cancer
amorphous solid
ing
rate
crystalline form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023151499A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024001040A (ja
Filing date
Publication date
Priority claimed from PCT/US2018/056083 external-priority patent/WO2019079299A1/en
Application filed filed Critical
Publication of JP2024001040A publication Critical patent/JP2024001040A/ja
Publication of JP2024001040A5 publication Critical patent/JP2024001040A5/ja
Pending legal-status Critical Current

Links

JP2023151499A 2017-10-16 2023-09-19 3-(5-フルオロベンゾフラン-3-イル)-4-(5-メチル-5H-[1,3]ジオキソロ[4,5-f]インドール-7-イル)ピロール-2,5-ジオンの固体形態 Pending JP2024001040A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762572603P 2017-10-16 2017-10-16
US62/572,603 2017-10-16
PCT/US2018/056083 WO2019079299A1 (en) 2017-10-16 2018-10-16 SOLID FORMS OF 3- (5-FLUOROBENZOFURAN-3-YL) -4- (5-METHYL-5H- [1,3] DIOXOLO [4,5-F] INDOL-7-YL) PYRROLE-2,5-DIONE
JP2020521319A JP7776258B2 (ja) 2017-10-16 2018-10-16 3-(5-フルオロベンゾフラン-3-イル)-4-(5-メチル-5H-[1,3]ジオキソロ[4,5-f]インドール-7-イル)ピロール-2,5-ジオンの固体形態

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020521319A Division JP7776258B2 (ja) 2017-10-16 2018-10-16 3-(5-フルオロベンゾフラン-3-イル)-4-(5-メチル-5H-[1,3]ジオキソロ[4,5-f]インドール-7-イル)ピロール-2,5-ジオンの固体形態

Publications (2)

Publication Number Publication Date
JP2024001040A JP2024001040A (ja) 2024-01-09
JP2024001040A5 true JP2024001040A5 (https=) 2026-01-28

Family

ID=64110166

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020521319A Active JP7776258B2 (ja) 2017-10-16 2018-10-16 3-(5-フルオロベンゾフラン-3-イル)-4-(5-メチル-5H-[1,3]ジオキソロ[4,5-f]インドール-7-イル)ピロール-2,5-ジオンの固体形態
JP2023151499A Pending JP2024001040A (ja) 2017-10-16 2023-09-19 3-(5-フルオロベンゾフラン-3-イル)-4-(5-メチル-5H-[1,3]ジオキソロ[4,5-f]インドール-7-イル)ピロール-2,5-ジオンの固体形態

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020521319A Active JP7776258B2 (ja) 2017-10-16 2018-10-16 3-(5-フルオロベンゾフラン-3-イル)-4-(5-メチル-5H-[1,3]ジオキソロ[4,5-f]インドール-7-イル)ピロール-2,5-ジオンの固体形態

Country Status (16)

Country Link
US (3) US11407759B2 (https=)
EP (1) EP3697794B1 (https=)
JP (2) JP7776258B2 (https=)
KR (1) KR102891811B1 (https=)
CN (1) CN111315748B (https=)
AU (1) AU2018352384B2 (https=)
CA (1) CA3074037A1 (https=)
DK (1) DK3697794T3 (https=)
ES (1) ES3064009T3 (https=)
FI (1) FI3697794T3 (https=)
IL (1) IL273920B2 (https=)
MX (1) MX2020003431A (https=)
PL (1) PL3697794T3 (https=)
PT (1) PT3697794T (https=)
WO (1) WO2019079299A1 (https=)
ZA (1) ZA202002740B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3697794T3 (pl) * 2017-10-16 2026-04-07 Actuate Therapeutics Inc. Stałe postacie 3-(5-fluorobenzofuran-3-ylo)-4-(5-metylo-5h-[1,3]dioksolo[4,5-f]indol-7-ilo)pirolo-2,5-dionu
WO2019222483A1 (en) * 2018-05-17 2019-11-21 Board Of Regents, The University Of Texas System Treatment of idiopathic pulmonary fibrosis with glycogen synthase kinase 3 form beta inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2673368C (en) 2006-12-19 2014-10-28 The Board Of Trustees Of The University Of Illinois 3-benzofuranyl-4-indolyl maleimides as potent gsk3 inhibitors for neurogenerative disorders
EP3665176B1 (en) * 2017-08-11 2024-01-24 Actuate Therapeutics Inc. Solid forms of 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5h[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione
PL3697794T3 (pl) * 2017-10-16 2026-04-07 Actuate Therapeutics Inc. Stałe postacie 3-(5-fluorobenzofuran-3-ylo)-4-(5-metylo-5h-[1,3]dioksolo[4,5-f]indol-7-ilo)pirolo-2,5-dionu

Similar Documents

Publication Publication Date Title
JP2024001040A5 (https=)
JP2023116503A5 (https=)
JP2010514807A5 (https=)
CA2687927A1 (en) Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
JP2022058395A5 (https=)
JP2025176008A5 (https=)
JP2022084717A5 (https=)
JP2016528179A5 (https=)
RU2009122241A (ru) Твердые формы рацемического илапразола
TWI303634B (en) 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,4']bipyridinyl in pure crystalline form, process for synthesis, and pharmaceutical composition containing the same
RU2012138892A (ru) СОЛИ И ПОЛИМОРФЫ 8-ФТОР-2-{4-[(МЕТИЛАМИНО)МЕТИЛ]ФЕНИЛ}-1,3,4,5,-ТЕТРАГИДРО-6Н-АЗЕПИНО[5,4,3-cd]ИНДОЛ-6-ОНА
JP2023082086A5 (https=)
CA2649022A1 (en) Cocrystal of c-glycoside derivative and l-proline
JP2023027066A5 (https=)
JP2009534373A5 (https=)
JP2010514725A5 (https=)
JP2021073270A5 (https=)
JP2005529084A5 (https=)
JPWO2020051538A5 (https=)
JP2004530706A (ja) 純粋な結晶形態にある5−クロロ−3−(4−メタンスルホニルフェニル)−6’−メチル−[2,3’]ビピリジニル及び合成方法
JPWO2023194339A5 (https=)
JPWO2020118113A5 (https=)
FI3697794T3 (fi) 3-(5-fluoribentsofuran-3-yyli)-4-(5-metyyli-5h-[1,3]dioksolo[4,5-f]indol-7-yyli)pyrroli-2,5-dionin kiinteitä muotoja
JPWO2019079299A5 (https=)
JP2012511571A5 (https=)